Corrections

Norway’s new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4666 (Published 20 July 2011) Cite this as: BMJ 2011;343:d4666

A mishap during editing caused the deletion of the first digit in each item of a bulleted list, leading to an overenthusiastic interpretation of Norway’s recommendations for preventive drug treatment in this article by Ole Frithjof Norheim and colleagues (BMJ 2011;343:d3626, doi:10.1136/bmj.d3626). The correct age groups for drug treatment are

  • 40–49 years: if 10 year risk of cardiovascular death is ≥1%

  • 50–59 years: if 10 year risk of cardiovascular death is ≥5%

  • 60–69 years: if 10 year risk of cardiovascular death is ≥10%.

Notes

Cite this as: BMJ 2011;343:d4666

View Abstract